Clinical trials
Myelodysplastic Syndromes trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Completed | 5 |
| Unknown status | 3 |
| Terminated | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut Paoli-Calmettes | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Assistance Publique Hopitaux De Marseille | 2 |
| Centre Leon Berard | 2 |
| Institut Claudius Regaud | 2 |
| Central Hospital, Nancy, France | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Hospices Civils de Lyon | 1 |
| Lille Catholic University | 1 |
| University Hospital, Bordeaux | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 19 |
| Leukemia, Myeloid, Acute | 4 |
| Anemia, Aplastic | 2 |
| Hematologic Neoplasms | 2 |
| Leukemia | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Myeloproliferative Disorders | 2 |
| Primary Myelofibrosis | 2 |
| Severe Combined Immunodeficiency | 2 |
| Blast Crisis | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.